1 – 100 of 422
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Association between breast cancer risk and disease aggressiveness : Characterizing underlying gene expression patterns (
- Obesity, Adipocytes and Breast Cancer – Insights from Translational Studies (
- RNA Sequencing for Molecular Diagnostics in Breast Cancer (
- 2020
- Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer (
- The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome (
- The generalisability of randomised clinical trials : an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer (
- Nutrient-wide association study of 92 foods and nutrients and breast cancer risk (
- The Menstrual Cycle and Risk of Breast Cancer : A Review (
- Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer (
- Risk-tailored starting age of breast cancer screening based on women's reproductive profile : A nationwide cohort study (
- Evaluation of associations between genetically predicted circulating protein biomarkers and breast cancer risk (
- The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice (
- Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history (
- Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial (
- Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences (
- Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment (
- Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (
- Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells (
- Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages (
- LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target (
- Changes in breast density over serial mammograms : A case-control study (
- Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer (
- Palpation of Increased Skin and Subcutaneous Thickness, Tissue Dielectric Constant, and Water Displacement Method for Diagnosis of Early Mild Arm Lymphedema (
- Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors : a Danish population-based cohort study (
- Mammographic density changes during neoadjuvant breast cancer treatment : NeoDense, a prospective study in Sweden (
- Do Women with Breast Cancer–related Lymphoedema Need to Wear Compression While Exercising? : Results from a Systematic Review and Meta-analysis (
- Breast reconstruction patterns from a Swedish nation-wide survey (
- Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression (
- Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells (
- Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment : Study protocol for the ReScreen randomized controlled trial (
- Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions - A feasibility study (
- Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium (
- Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis (
- Physical activity and breast cancer. Risk, survival and perceived energy. (
- Discrimination between breast cancer cells and white blood cells by non-invasive measurements : Implications for a novel in vitro-based circulating tumor cell model using digital holographic cytometry (
- The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome (
- CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients (
- Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery : a long-term follow-up of the SweBCG91-RT randomised trial (
- Drug use disorder and risk of incident and fatal breast cancer : a nationwide epidemiological study (
- Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ : a prospective cohort study (
- The Usefulness of Brief Family Health Conversations Offered to Families Following the Diagnosis of Breast Cancer (
- Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients (
- Prevention of arm lymphedema through the use of compression sleeves following breast cancer : results from a targeted literature review (
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (
- Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer (
- Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression (
- Prediagnostic serum selenium levels in relation to breast cancer survival and tumor characteristics (
- Solvent fractions of selected Ethiopian medicinal plants used in traditional breast cancer treatment inhibit cancer stem cells in a breast cancer cell line (
- Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer : data from a randomised trial with long-term follow-up (
- Identifying normal mammograms in a large screening population using artificial intelligence (
- 2019
- High patient satisfaction with a simplified BRCA1/2 testing procedure : long-term results of a prospective study (
- Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort (
- Blood levels of cadmium and lead in relation to breast cancer risk in three prospective cohorts (
- Conceptualizing multiple drug use in patients with comorbidity and multimorbidity : proposal for standard definitions beyond the term polypharmacy (
- Statin use and breast cancer survival - A Swedish nationwide study (
- The association between weight at birth and breast cancer risk revisited using Mendelian randomisation (
- Breast cancer imaging - A rapidly evolving discipline (
- Volumetric breast density measurement for personalized screening : Accuracy, reproducibility, consistency, and agreement with visual assessment (
- Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study (
- Afadin cooperates with Claudin-2 to promote breast cancer metastasis (
- Immune Tolerance Mechanisms in Human Breast Cancer (
- Breast cancer and axillary lymph node status : Pre-operative clinicopathological predictors of axillary metastasis (
- The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer (
- Assessing lesion malignancy by scanning small-angle x-ray scattering of breast tissue with microcalcifications (
- Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification (
- Vitamin D receptor expression in invasive breast tumors and breast cancer survival (
- Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment (
- Artificial neural network models to predict nodal status in clinically node-negative breast cancer (
- 2018
- A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1) (
- Prognostic and Predictive Markers in Primary Breast Cancer - Quality Assurance and Long-term Effects of Adjuvant tamoxifen Treatment (
- The role of breast tomosynthesis in a predominantly dense breast population at a tertiary breast centre : breast density assessment and diagnostic performance in comparison with MRI (
- Increasing preoperative body size in breast cancer patients between 2002 and 2016 : implications for prognosis (
- Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment (
- Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors (
- Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo (
- Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients (
- Clinical Studies of EpECT with Bleomycin or Cis-Platin (
- Not all those who wander are lost : A study of cancer cells by digital holographic imaging, fluorescence and a combination thereof (
- Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer (
- Dosimetric effects of breathing motion in radiotherapy (
- Volumetric breast density measurement for personalized screening : Accuracy, reproducibility, and agreement with visual assessment (
- Long-term exposure to insulin and volumetric mammographic density : Observational and genetic associations in the Karma study (
- A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients : Study protocol of the SCAN-B resilience study (
- Re-inforcing the cell death army in the fight against breast cancer (
- Growth factor signaling in the breast tumor microenvironment (
- The role of phosphatidylinositol 4-phosphate 5-kinase type І alpha (PIP5K1α) and utility of its inhibitor for targeting metastatic cancer (
- Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer (
- Statins : a role in breast cancer therapy? (
- Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer (
- Breast ultrasound : recommendations for information to women and referring physicians by the European Society of Breast Imaging (
- WNT5A as a therapeutic target in breast cancer (
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (
- Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study (
- Predictors of Lymph Node Metastasis in Primary Breast Cancer - Risk Models for Tailored Axillary Management (
- Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative (
- Use of the BOADICEA Web Application in clinical practice : appraisals by clinicians from various countries (
- Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial (
- BRCAsearch : written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer (
- Liposuction of lymphedema: Treatment strategy, pathophysiology and long-term outcome (
- One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection : do we need more? (